Trump Credits 60-Year Drug Price Drop to Himself, Experts Disagree

TL/DR –

The White House attributed a 3.1% decrease in prescription drug prices, the largest in over 60 years, to President Trump’s administration, but experts cited in a Washington Post report attribute this reduction to policies from Biden’s era, particularly the Inflation Reduction Act’s Medicare negotiations. Harvard’s Richard Frank and Vanderbilt’s Stacie Dusetzina suggest that the existing legislation is more likely the cause of the price decrease than any of Trump’s efforts. While Trump used the stats to promote his success, experts maintain that the 10 drugs already negotiated under the new law are widely used and would likely be reflected in the prescription drug index.

“`html

Prescription Drug Prices Experience Record Drop, but Credit is Under Dispute

Prescription drug prices have seen a historic decrease recently, falling by 3.1%, the largest drop in over 60 years. The White House attributed this significant decline to the policies of President Trump. However, experts, including Harvard professor Richard Frank and Vanderbilt’s Stacie Dusetzina, argue that this drop is due to Biden-era laws, specifically the Medicare negotiations under the Inflation Reduction Act. They contend that these have a higher likelihood of driving down the prices than any efforts made by Trump.

White House Attributes Drop to Trump’s Success

The White House publicized a Washington Post headline last Saturday, which highlighted the unprecedented drop in prescription drug prices. This was presented as a testament to President Donald Trump‘s success. This assertion was made despite the article’s own experts indicating that a policy from Biden’s era was a more likely contributor to this decline.

Biden-Era Law Likely Cause, Say Experts

Consumer Price Index data from the Bureau of Labor Statistics shows a 3.1% drop in prescription drug prices in July. According to independent experts quoted by the Washington Post, this decrease is most likely linked to the Inflation Reduction Act, enacted under Joe Biden in 2022. The Act mandated Medicare drug-price negotiations, a policy that these experts believe has more impact than any measures taken by the Trump administration.

Richard Frank, professor emeritus of health economics at Harvard University, stated that if he were to guess the cause of the price drop, he would attribute it to “stuff around the Inflation Reduction Act.” He further added that Trump’s efforts “wouldn’t be where I’d place my money.”

Agreeing with Frank, Vanderbilt’s Stacie Dusetzina pointed out that the prescription drug index would likely reflect the prices of the 10 drugs already negotiated under the Inflation Reduction Act, given their wide usage.

Trump Heralds Drug-Price Headline

President Trump showcased the headline on Friday, announcing, “I told you that was going to happen.” The official White House social media accounts echoed his sentiment, posting the caption, “POV: you bring the receipts.” Press Secretary Karoline Leavitt also shared the image.

White House Communications Director Steven Cheung posted a screenshot of the headline on X, the same day the paper was published. His caption read, “All thanks to President Trump!” but did not provide a link to the article.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Read Also:

Big Pharma’s Future Growth Rests on Chinese Science? Expert Says: ‘We Can’t Ban Our Way Out of This’

Photo courtesy: Shutterstock

“`
—
Read More US Economic News